Actylis announced the opening of a new 30,000ft2cGMP facility in Eugene, OR (USA). The Eugene facility is the latest GMP manufacturing facility that Actylis has commissioned along with the other GMP sites in Montreal (Canada), Limerick (Ireland) and Ahmedabad (India), Actylis boasts a presence in 10 countries spanning three continents and offers more than 4,500 products. Actylis offers customers the flexibility to choose from a wide range of individualized solutions, all backed by the same world-class quality, supply chain reliability and regulatory expertise.

Its capabilities encompass the entire R&D, product development and manufacturing spectrum, including technical sales support, R&D, manufacturing and production, quality, supply chain, global sourcing, and regulatory compliance.